Sign In  |  Register  |  About Walnut Creek Guide  |  Contact Us

Walnut Creek, CA
September 01, 2020 1:43pm
7-Day Forecast | Traffic

  • Search Hotels in Walnut Creek Guide

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Boston Scientific (NY: BSX )

88.25 +1.37 (+1.58%)
Official Closing Price Updated: 6:30 PM EST, Nov 8, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Boston Scientific

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Boston Scientific Surges As It Looks To Enter A Market Worth Nearly $8 Billion
The company tested a new means of treating abnormal heartbeats. 
Via Investor's Business Daily
German Pharma Firm Bayer's New Parkinson's Treatment Shows Promise: What the Phase 1 Trial Reveals
Boston Scientific Corporation (NYSE: BSX) released 12-month results from the pivotal ADVENT trial of the FARAPULSE Pulsed Field Ablation (PFA) System, a nonthermal treatment in which electric fields... 
Via Benzinga
Why Is Boston Scientific Stock Trading Higher Today?
Boston Scientific Corporation (NYSE: BSX) released 12-month results from the pivotal ADVENT trial of the FARAPULSE Pulsed Field Ablation (PFA) System, a nonthermal treatment in which electric fields... 
Via Benzinga
Analyst Expectations for Boston Scientific's Future
Via Benzinga
Boston Scientific Stock Gets 81 RS Rating After Profit Pops 56% In Year
Boston Scientific stock rose from a 34.98 low on June 16, 2022, amid the bear market, to an all-time high 54.66 close on June 22 this year. 
Via Investor's Business Daily
Target, Pinterest And 2 Other Stocks Insiders Are Selling
The Nasdaq 100 closed slightly lower on Tuesday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
$100 Invested In This Stock 15 Years Ago Would Be Worth $400 Today
Via Benzinga
How Is The Market Feeling About Boston Scientific?
Via Benzinga
Here's How Much $100 Invested In Boston Scientific 10 Years Ago Would Be Worth Today
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Boston Scientific's Farapulse Eyes Stronger US Market Position With Potential FDA Approval
Boston Scientific Corp (NYSE: BSX) will present results from ADVENT pivotal trial for its Farapulse Pulsed Field Ablation (PFA) system at the 2023 European Society of Cardiology Congress on 27 August.... 
Via Benzinga
Exposures Product Safety
Barron's Weekend Stock Picks: PayPal, Nikola And Icahn Enterprises' Challenges
Benzinga reviews this weekend's top stories covered by Barron's. Here are the articles investors need to read. 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Expert Ratings for Boston Scientific
Via Benzinga
How Is The Market Feeling About Boston Scientific?
Via Benzinga
$1000 Invested In This Stock 10 Years Ago Would Be Worth $5,500 Today
Via Benzinga
What 16 Analyst Ratings Have To Say About Boston Scientific
Via Benzinga
Boston Scientific Q2 Earnings Surpass Estimates - Here's How It Foresees FY23
Boston Scientific Corp (NYSE: BSX) generated Q2 revenues of $3.59 billion, beating the Wall Street estimate of $3.50 billion 
Via Benzinga
BSX Stock Near Buy Point: Boston Scientific Earnings Beat; Medical Giant Raises Guidance
BSX stock rose slightly, near a buy point. 
Via Investor's Business Daily
Big Weeks Ahead For MedTech And Life Science Stocks
It’s a big week for earnings that may change the trajectory of the rally but more than likely will continue the rotation into different sectors. 
Via Talk Markets
Peering Into Boston Scientific's Recent Short Interest
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 30, 2023
Via Benzinga
Here's How Much $1000 Invested In Boston Scientific 10 Years Ago Would Be Worth Today
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 19, 2023
Via Benzinga
Expert Ratings for Boston Scientific
Via Benzinga
DexCom Clears Base, Wall Street Eyes Double-Digit Earnings Growth
DexCom's G7 glucose-monitoring solution is driving revenue growth at the company. Analysts expect strong double-digit EPS growth this year and next. 
Via MarketBeat
Here's How Much $1000 Invested In Boston Scientific 10 Years Ago Would Be Worth Today
Via Benzinga
Healthcare Stocks Delivering Healthy Returns: 5 Stock Picks Investors Are Keeping On Their Radar
Demand for healthcare and healthcare insurance is projected to see continuous growth over the coming months. 
Via Talk Markets
Surgical Centers, Med-Tech Stocks Up On Pent-Up Surgical Demand
Surgery centers and medtech firms see a surge in demand as joint replacements and other elective surgeries are rescheduled, causing challenges for insurers. 
Via MarketBeat
UnitedHealth's Bad News Hits Insurers, But Surgery Partners Signals Breakout
UNH stock slumped after UnitedHealth said more seniors are getting hip and surgery procedures. That sent Surgery Partners stock soaring. 
Via Investor's Business Daily
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 WalnutCreekGuide.com & California Media Partners, LLC. All rights reserved.